PRTA - Prothena Corporation plc

NasdaqGS - NasdaqGS Delayed Price. Currency in USD
Income Statement
Balance Sheet
Cash Flow

Income Statement

All numbers in thousands
Total Revenue1,0551,60750,854
Cost of Revenue---
Gross Profit1,0551,60750,854
Operating Expenses
Research Development119,53458,43938,452
Selling General and Administrative41,05623,10519,051
Non Recurring---
Total Operating Expenses---
Operating Income or Loss-159,535-79,937-6,649
Income from Continuing Operations
Total Other Income/Expenses Net57126310
Earnings Before Interest and Taxes-158,964-79,911-6,339
Interest Expense---
Income Before Tax-158,964-79,911-6,339
Income Tax Expense1,144701811
Minority Interest---
Net Income From Continuing Ops-160,108-80,612-7,150
Non-recurring Events
Discontinued Operations---
Extraordinary Items---
Effect Of Accounting Changes---
Other Items---
Net Income
Net Income-160,108-80,612-7,150
Preferred Stock And Other Adjustments---
Net Income Applicable To Common Shares-160,108-80,612-7,150